Alberto Rocci

2.8k total citations
32 papers, 661 citations indexed

About

Alberto Rocci is a scholar working on Hematology, Molecular Biology and Physiology. According to data from OpenAlex, Alberto Rocci has authored 32 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 15 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Alberto Rocci's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Alberto Rocci is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Alberto Rocci collaborates with scholars based in Italy, United States and United Kingdom. Alberto Rocci's co-authors include Antonio Palumbo, Manuela Gambella, Craig C. Hofmeister, Mario Boccadoro, Dawn Swan, Jecko Thachil, Charlotte Bradbury, Marco Ladetto, Niklas Zojer and S Caltagirone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Alberto Rocci

31 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Rocci Italy 14 417 373 170 99 99 32 661
Nicolas Goardon France 16 470 1.1× 249 0.7× 160 0.9× 91 0.9× 162 1.6× 29 905
Kimihito C. Kawabata Japan 9 323 0.8× 291 0.8× 90 0.5× 123 1.2× 95 1.0× 18 529
YinWei Ho United States 10 608 1.5× 530 1.4× 262 1.5× 263 2.7× 96 1.0× 14 1.1k
Laura Barreyro United States 12 375 0.9× 512 1.4× 127 0.7× 154 1.6× 301 3.0× 19 855
Carolien M. Woolthuis Netherlands 13 532 1.3× 531 1.4× 152 0.9× 125 1.3× 210 2.1× 21 980
Peter J. Kourlas United States 6 291 0.7× 170 0.5× 81 0.5× 72 0.7× 86 0.9× 11 578
Anita M. Schelen Netherlands 9 284 0.7× 313 0.8× 268 1.6× 156 1.6× 277 2.8× 13 778
Hisao Nagoshi Japan 12 299 0.7× 149 0.4× 136 0.8× 54 0.5× 146 1.5× 38 520
Marielle Chiron France 12 299 0.7× 321 0.9× 440 2.6× 81 0.8× 125 1.3× 44 745
Uta Bertsch Germany 15 852 2.0× 920 2.5× 577 3.4× 92 0.9× 73 0.7× 42 1.2k

Countries citing papers authored by Alberto Rocci

Since Specialization
Citations

This map shows the geographic impact of Alberto Rocci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Rocci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Rocci more than expected).

Fields of papers citing papers by Alberto Rocci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Rocci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Rocci. The network helps show where Alberto Rocci may publish in the future.

Co-authorship network of co-authors of Alberto Rocci

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Rocci. A scholar is included among the top collaborators of Alberto Rocci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Rocci. Alberto Rocci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tao, Ahmed Sawas, Wan‐Jen Hong, et al.. (2023). RWD-derived response in multiple myeloma. PLoS ONE. 18(5). e0285125–e0285125. 1 indexed citations
2.
3.
Glavey, Siobhan, Alexandra Naba, Salomon Manier, et al.. (2017). Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. Leukemia. 31(11). 2426–2434. 65 indexed citations
4.
Harshman, Sean W., Alessandro Canella, Kitty Agarwal, et al.. (2016). Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. Journal of Proteomics. 136. 89–98. 72 indexed citations
5.
Gambella, Manuela, Antonio Palumbo, & Alberto Rocci. (2015). MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?. Expert Review of Molecular Diagnostics. 15(7). 881–893. 12 indexed citations
6.
Gambella, Manuela, Alberto Rocci, Roberto Passera, et al.. (2014). High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. Haematologica. 99(2). e14–e16. 47 indexed citations
7.
Gambella, Manuela, Paola Omedè, Stefania Oliva, et al.. (2014). In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide. Blood. 124(21). 3394–3394. 2 indexed citations
8.
Rocci, Alberto, Craig C. Hofmeister, & Flavia Pichiorri. (2014). The potential of miRNAs as biomarkers for multiple myeloma. Expert Review of Molecular Diagnostics. 14(8). 947–959. 22 indexed citations
9.
Cerrato, Chiara, Maria Teresa Petrucci, Mariella Genuardi, et al.. (2013). A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma. Blood. 122(21). 685–685. 7 indexed citations
10.
Bonanno, Giuseppina, Andrea Mariotti, Annabella Procoli, et al.. (2012). Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. Journal of Translational Medicine. 10(1). 247–247. 56 indexed citations
11.
Agnelli, Luca, Paola Storti, Katia Todoerti, et al.. (2011). Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations. American Journal of Hematology. 86(12). E64–6. 10 indexed citations
12.
Aspesi, Anna, Stefano Vallero, Alberto Rocci, et al.. (2010). Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia. Pediatric Blood & Cancer. 55(3). 550–553. 9 indexed citations
13.
14.
Ruella, Marco, Alberto Rocci, Irene Ricca, et al.. (2009). Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status. Bone Marrow Transplantation. 45(3). 505–512. 13 indexed citations
15.
Pavesi, Elisa, Anna Aspesi, Paola Quarello, et al.. (2009). Analysis of telomeres in peripheral blood cells from patients with bone marrow failure. Pediatric Blood & Cancer. 53(3). 411–416. 19 indexed citations
16.
17.
Ricca, Irene, Alberto Rocci, Daniela Drandi, et al.. (2007). Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients. Leukemia. 21(4). 697–705. 33 indexed citations
18.
Ladetto, Marco, Mara Compagno, Irene Ricca, et al.. (2004). Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood. 103(12). 4644–4649. 30 indexed citations
19.
Ladetto, Marco, Barbara Mantoan, Irene Ricca, et al.. (2003). Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. Experimental Hematology. 31(9). 784–788. 9 indexed citations
20.
Ceda, Gian Paolo, E. Dall’Aglio, Alberto Rocci, et al.. (2002). Growth hormone (GH) and insulin-like growth factor-1 (ICF-1) in the elderly: clinical trial results. Archives of Gerontology and Geriatrics. 35. 81–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Goardon Breakdown of academic impact, for papers by Kimihito C. Kawabata Breakdown of academic impact, for papers by YinWei Ho Breakdown of academic impact, for papers by Laura Barreyro Breakdown of academic impact, for papers by Carolien M. Woolthuis Breakdown of academic impact, for papers by Peter J. Kourlas Breakdown of academic impact, for papers by Anita M. Schelen Breakdown of academic impact, for papers by Hisao Nagoshi Breakdown of academic impact, for papers by Marielle Chiron Breakdown of academic impact, for papers by Uta Bertsch
Rankless by CCL
2026